Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BCDA - BioCardia gets positive DSMB recommendation for late-stage heart failure study


BCDA - BioCardia gets positive DSMB recommendation for late-stage heart failure study

BioCardia (BCDA) announces that the independent Data Safety Monitoring Board ((DSMB)) has recommended that the company continue with its late-stage heart failure trial as designed.The DSMB's recommendation comes after it completed a prespecified data review for the Phase III pivotal CardiAMP cell therapy heart failure trial.The ongoing multi-center, double-blinded, randomized (3:2), controlled pivotal CardiAMP heart failure trial is expected to enroll 260 patients at up to 40 centers nationwide.The trial’s primary endpoint is an outcomes composite score based on a three-tiered Finkelstein-Schoenfeld ((FS)) hierarchical analysis, an established outcomes design that has been used in other leading heart failure programs.

For further details see:

BioCardia gets positive DSMB recommendation for late-stage heart failure study
Stock Information

Company Name: BioCardia Inc.
Stock Symbol: BCDA
Market: NASDAQ
Website: biocardia.com

Menu

BCDA BCDA Quote BCDA Short BCDA News BCDA Articles BCDA Message Board
Get BCDA Alerts

News, Short Squeeze, Breakout and More Instantly...